Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk

Croatian Medical Journal

Volumn 55, Issue 6, 2014, Pages 638-646

  Wang, Zhi ^a   Liu, Qiu Lian ^a   Sun, Wu ^a   Yang, Chun Jing ^a   Tang, Lei ^a   Zhang, Xian ^a   Zhong, Xiao Ming ^b  

^a Department of Oncology Jiujiang First People's Hospital   (China)

^b Jiangxi Province Cancer Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; I KAPPA B; IL10 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; NF-KAPPAB INHIBITOR ALPHA; NFKB1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MENOPAUSE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-10; INTERLEUKIN-8; MIDDLE AGED; NEOPLASM PROTEINS; NF-KAPPA B P50 SUBUNIT; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921643496     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2014.55.638     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. Medline:21296855 doi:10.3322/caac.20107.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 (Internet). Lyon: International Agency for Research on Cancer; 2010.
3. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358:213-6. Medline:18199859 doi:10.1056/NEJMp0708307.
4. Njiaju UO, Olopade OI. Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application. Breast J. 2012;18:436-42. Medline:22957996 doi:10.1111/j.1524-4741.2012.01274.x.
5. Newman B, Austin MA, Lee M, King M. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A. 1988;85:3044-8. Medline:3362861 doi:10.1073/pnas.85.9.3044.
6. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, et al. The functional-94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37:634-8. Medline:23806437 doi:10.1016/j.canep.2013.05.007.
7. Tan SC, Suzairi MS, Aizat AA, Aminudin MM, Nurfatimah MS, Bhavaraju VM, et al. Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer. Med Oncol. 2013;30:693. Medline:23996241 doi:10.1007/s12032-013-0693-6.
8. Song B, Zhang D, Wang S, Zheng H, Wang X. Association of interleukin-8 with cachexia from patients with low-third gastric cancer. Comp Funct Genomics. 2009;212345. Medline:20037740.
9. Lajin B, Hamzeh AR, Ghabreau L, Mohamed A, Moustafa AA, Alachkar A. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria. Breast Cancer. 2013;20:62-6. Medline:22124994 doi:10.1007/s12282-011-0309-y.
10. Wang J, Guo X, Zhang J, Song J, Ji M, Yu S, et al. Cyclooxygenase-2 polymorphisms and susceptibility to colorectal cancer: a metaanalysis. Yonsei Med J. 2013;54:1353-61. Medline:24142638 doi:10.3349/ymj.2013.54.6.1353.
11. Pooja S, Francis A, Bid HK, Kumar S, Rajender S, Ramalingam K, et al. Role of ethnic variations in TNF-a and TNF-ß polymorphisms and risk of breast cancer in India. Breast Cancer Res Treat. 2011;126:739-47. Medline:20878356 doi:10.1007/s10549-010-1175-6.
12. Constantinou C, Fentiman IS. Inflammation and breast cancer. Breast Cancer Management. 2013;2:311-25. doi:10.2217/bmt.13.26.
13. Abraham LJ, Kroeger KM. Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999;66:562-6. Medline:10534109.
14. Mohebbatikaljahi H, Menevse S, Yetkin I, Demirci H. Study of interleukin-10 promoter region polymorphisms (-1082A/G,-819T/C and-592A/C) in type 1 diabetes mellitus in Turkish population. J Genet. 2009;88:245-8. Medline:19700864 doi:10.1007/s12041-009-0034-x.
15. Stayoussef M, Benmansour J, Al-Jenaidi FA, Rajab MH, Said HB, Ourtani M, et al. Identification of specific tumor necrosis factor-a-susceptible and-protective haplotypes associated with the risk of type 1 diabetes. Eur Cytokine Netw. 2010;21:285-91. Medline:21097392.
16. DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res. 2007;9:212. Medline:17705880 doi:10.1186/bcr1746.
17. Baumgarten SC, Frasor J. Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol. 2012;26:360-71. Medline:22301780 doi:10.1210/me.2011-1302.
18. Maccin A, Madeddu C. Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. ScientificWorldJournal. 2011;11:2020-36. Medline:22125453 doi:10.1100/2011/806787.
19. Murata M, Thanan R, Ma N, Kawanishi S. Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J Biomed Biotechnol. 2012;623019. Medline:22363173.
20. Li P, Gu J, Yang X, Cai H, Tao J, Yang X, et al. Functional promoter-94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLoS ONE. 2013;8:e71604. Medline:23977085 doi:10.1371/journal.pone.0071604.
21. Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z, et al. NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS ONE. 2011;6:e21726. Medline:21738780 doi:10.1371/journal.pone.0021726.
22. Curran JE, Weinstein SR, Griffiths LR. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett. 2002;188:103-7. Medline:12406554 doi:10.1016/S0304-3835(02)00460-3.
23. Liu JY, Zhai XJ, Jin GF. A study of relationship between polymorphisms of interleukin-8 and risk of breast cancer in Chinese population. Bulletin of Chinese Cancer. 2007;6:8-10.
24. Kamali-Sarvestani E, Aliparasti MR, Atefi S. Association of interleukin-8 (IL-8 or CXCL8)-251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer. Neoplasma. 2007;54:484-9. Medline:17949231.
25. Kong F, Liu J, Liu Y, Song B, Wang H, Liu W. Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J Exp Clin Cancer Res. 2010;29:72. Medline:20553628 doi:10.1186/1756-9966-29-72.
26. Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, et al. Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat. 2009;114:347-55. Medline:18409070 doi:10.1007/s10549-008-0006-5.
27. Park KS, Mok JW, Ko HE, Tokunaga K, Lee MH. Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur J Immunogenet. 2002;29:7-10. Medline:11841482 doi:10.1046/j.0960-7420.2001.00260.x.